Medicina neonatal
Prevenção de anemia induzida por medicamentos ou trombocitopenia
Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (abre nova janela)
Fonte: J Pediatr 2013;163(1):23-8.
Indexado: PubMed 23351600
DOI: 10.1016/j.jpeds.2012.12.035
https://www.ncbi.nlm.nih.gov/pubmed/23351600 (abre nova janela)
Natalizumab use during the third trimester of pregnancy. (abre nova janela)
Fonte: JAMA Neurol 2014;71(7):891-5.
Indexado: PubMed 24821217
DOI: 10.1001/jamaneurol.2014.209
https://www.ncbi.nlm.nih.gov/pubmed/24821217 (abre nova janela)
Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (abre nova janela)
Fonte: Klin Padiatr 2013;225(5):263-5.
Indexado: PubMed 23519748
DOI: 10.1055/s-0033-1333756
https://www.ncbi.nlm.nih.gov/pubmed/23519748 (abre nova janela)
Drug-induced thrombocytopenia in children. (abre nova janela)
Fonte: Pediatr Blood Cancer 2013;60(12):1975-81.
Indexado: PubMed 24038783
DOI: 10.1002/pbc.24682
https://www.ncbi.nlm.nih.gov/pubmed/24038783 (abre nova janela)